Top Markets
Coin of the day
Immunotech Biopharm Ltd Immunotech Biopharm Ltd

Immunotech Biopharm Ltd

6978
Clasificación en acciones #27803
Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in... Immunotech Biopharm Ltd operates as a biopharmaceutical firm specializing in cellular immunotherapy. Its primary activities involve the investigation, development, and market introduction of T cell-based immunotherapy solutions for various cancers within the People's Republic of China. The company's flagship product, EAL, is a multi-target cellular immunotherapy currently undergoing Phase II clinical trials for the purpose of preventing liver cancer recurrence after surgery. Furthermore, Immunotech Biopharm is conducting both preclinical and clinical research on EAL for its potential use in treating lung cancer, glioma, gastric cancer, and colorectal cancer. Other pipeline assets include the 6B11-OCIK injection, which is in Phase I trials for ovarian cancer; the CAR-T-19 injection product, targeting B-cell acute lymphoblastic leukaemia; and a range of TCR-T cell products designed for solid tumor treatment. Established in 2006, the company's main office is located in Beijing, China.
Precio por acción
$0.0492516
Capitalización bursátil
$30.41M
Cambio (1 día)
1.32%
Cambio (1 año)
-91.28%
País
CN
Comercio Immunotech Biopharm Ltd (6978)

Categoría

Historial del precio de la acción de Immunotech Biopharm Ltd (6978)
Precio más alto de cierre: $0.05 el 2026-08-01

Precio más bajo de cierre: $1.62 el 2020-07-01
Historial del precio de la acción de Immunotech Biopharm Ltd desde 2020 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -16.14%
2025 18.05%
2024 -39.42%
2023 -16.02%
2022 -68.58%
2021 55.17%
2020 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$552.07 39.99%
US
$168.77 527.63%
US
$1.03K 56.22%
NL
$120.74 -14.98%
AU
$759.01 6.64%
CH